Astronics (ATRO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
17 Apr, 2026Executive summary
Annual meeting scheduled for May 28, 2026, with shareholders voting on key proposals including director elections, auditor ratification, executive compensation, and new incentive plans.
FY 2025 sales reached $862.1 million, surpassing pre-pandemic levels, with 92% from aerospace and 8% from test systems.
Institutional ownership stands at 84.6% with 32,064,056 common shares and 3,810,280 Class B shares outstanding as of the record date.
Voting matters and shareholder proposals
Election of nine directors for one-year terms.
Ratification of Ernst & Young LLP as independent auditor for FY 2026.
Advisory vote on executive compensation (say-on-pay), held triennially.
Approval of the 2026 Long Term Incentive Plan (LTIP) and 2026 Employee Stock Purchase Plan (ESPP).
Board of directors and corporate governance
Board consists of nine members, eight of whom are independent; all committees are fully independent.
Annual election of directors, average tenure is 12 years, and two women serve on the board.
Lead independent director role established; annual board and committee self-evaluations conducted.
Stock ownership requirements for directors set at 400% of annual cash retainer.
Board oversight includes CEO succession planning and risk management.
Latest events from Astronics
- Key votes include director elections, auditor ratification, and new incentive plan approvals.ATRO
Proxy filing17 Apr 2026 - Strong 2025 growth, margin expansion, and innovation drive robust outlook and financial flexibility.ATRO
Investor presentation24 Mar 2026 - Record backlog, innovation, and improved margins drive strong 2026 growth outlook.ATRO
TD Cowen 47th Annual Aerospace & Defense Conference21 Mar 2026 - Aerospace and defense growth accelerates with margin gains, strong backlog, and innovation.ATRO
Sidoti Small-Cap Virtual Investor Conference21 Mar 2026 - 2025 growth moderates as defense wins, backlog, and supply chain gains drive future potential.ATRO
CJS Securities 25th Annual “New Ideas for the New Year” Investor Conference21 Mar 2026 - Record backlog, raised guidance, and major wins drive growth and margin improvement.ATRO
15th Annual Midwest IDEAS Investor Conference21 Mar 2026 - Record Q4 revenue, margin gains, and backlog support double-digit 2026 growth outlook.ATRO
Q4 202524 Feb 2026 - Record sales, innovation, and major contracts drive strong recovery and margin expansion.ATRO
16th Annual Midwest Ideas Conference3 Feb 2026 - Q2 sales up 14% to $198.1M, net income $1.5M, and 2024 guidance raised to $780–$800M.ATRO
Q2 20242 Feb 2026